Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 8/27/2008 First Published: 3/24/2004


1.		Phase II Pilot Chemoprevention Study of Deslorelin in Combination With Low-Dose Add-Back Estradiol and Testosterone in Premenopausal Women With or Without a BRCA Gene Mutation Who Are at High Risk for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Prevention				Active				21 to 48				NCI				CHNMC-IRB-02164 NCT00080756


2.		Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care				Active				18 to 85				Other				ART2 NCT00497458


3.		Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Over 18				Other				15393B NCT00515112

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute